Results 211 to 220 of about 29,739 (258)

Potentiation of cancer immunogenicity by targeting PARP. [PDF]

J Immunother Cancer
Humer D, Klepsch V, Baier G.
europepmc   +1 more source

Deltex and RING-UIM E3 ligases cooperate to create a ubiquitin-ADP-ribose hybrid mark on tankyrase, promoting its stabilization. [PDF]

Sci Adv
Perrard J, Gao K, Ring K, Smith S.
europepmc   +1 more source

Nucleosome unwrapping and PARP1 allostery drive affinities for chromatin and DNA breaks. [PDF]

Nat Commun
Schaich MA, Weaver TM, Rakowski JA, Roginskaya V, Leary LP, Van den Berg AA, Iwasa JH, Freudenthal BD, Van Houten B.   +8 more
europepmc   +1 more source

dELTA-MS: A Mass Spectrometry-Based Proteomics Approach for Identifying ADP-Ribosylation Sites and Forms. [PDF]

J Proteome Res
Uribe IR, Zahn E, Searfoss R, Kim HB, Dasovich M, Voorneveld J, Hunt SR, Onuoha UC, Valadez C, Filippov DV, Na CH, Garcia BA, Orsburn BC, Leung AKL.   +13 more
europepmc   +1 more source

Transcriptional and Metabolic Networks Underlying Melanin Deposition in Silkie Chicken Muscle: A Multi-Omics Insights. [PDF]

Animals (Basel)
Pan Y, Zhang L, Yue X, Sun Z, Zhang H, Si X, Zheng R, Chen W, Zhang M, Huang Y.   +9 more
europepmc   +1 more source

Convergent Approach Toward ADP-Ribosylated Peptides via a Chemoselective Phosphate Condensation. [PDF]

Chemistry
Wijngaarden S, van der Heijden FLAM, Bogaart CJ, Siskou M, Tsoumani I, Robinson DJ, van der Marel GA, Codée JDC, Overkleeft HS, Filippov DV.   +9 more
europepmc   +1 more source

Structural Modeling of NTPDase-Substrate Complexes Preserving Catalytic Experimental Features. [PDF]

ACS Omega
de Moraes JVB, Polêto MD, de Castro RB, Bressan GC, de S Vasconcellos R, Sévigny J, Fietto JR.   +6 more
europepmc   +1 more source

PARG Mutation Uncovers Critical Structural Determinant for Poly(ADP-Ribose) Hydrolysis and Chromatin Regulation in Embryonic Stem Cells. [PDF]

Cells
Karpova Y, Piatz S, Bordet G, Tulin AV.
europepmc   +1 more source

Mutations differentially affecting the coronavirus Mac1 ADP-ribose binding and hydrolysis activities indicate that it promotes multiple stages of the viral replication cycle. [PDF]

J Virol
O'Connor JJ, Roy A, Khattabi R, Kerr C, Schwarting N, Alhammad YM, Gao P, Zhang X, Deng X, Fehr AR.   +9 more
europepmc   +1 more source

PARPs and PARP inhibitors: molecular mechanisms and clinical applications. [PDF]

Mol Biomed
Wang F, Guo Z, Carr MJ, Shi W.
europepmc   +1 more source